Electronic Medication Management

Managing the processes of prescribing, dispensing, administering and monitoring of medicines is an integral part of ensuring good health outcomes for all Australians and ensuring cost effective use of medicines.

Improving medications management in Australia is a key objective of the National Quality Use of Medicines Strategy and the National Medicines Policy. Electronic Medication Management seeks to support these policies and objectives by improving the quality and availability of medicines-related information.

Australian Digital Health Agency’s Medicines Safety Program

The Medicines Safety strategic priority in the National Digital Health Strategy recognises that the use of medicines is the most common intervention made in health care, which means that problems with medicine use are also common. The Pharmaceutical Society of Australia’s (PSA) Medicine Safety: Take care report released in February 2019 demonstrated that 250,000 hospital admissions annually are a result of medication-related problems and incur an annual cost of $1.4 billion.

But 50% of this harm is potentially preventable. Medication errors have a disproportionate impact on older Australians, and 98% of residential aged care residents have at least one medication-related problem.

The Agency’s Medicines Safety Program is focussed on improving access to information about medicines, allergies and adverse reactions, to support safe and efficient medicines use and reduce adverse medication events by implementing a nationally coordinated digital medicines safety program to increase the safety and quality of medicines use across health and care.

Through 2018-19 the Medicines Safety Program has delivered in accordance with its workplan across three major projects:

  1. Pharmacist Shared Medicines List (PSML)
  2. Electronic Prescriptions
  3. Digital Medicines Program Blueprint

The Agency’s Programs Direction Committee provides governance over the Medicines Safety Program and external stakeholder and advisory input is provided by the Medicines Safety Program Steering Group.

For more information on the program, contact the Medicines Safety Program Director.